Dcm Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Dcm Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$86.42 - $109.81 $715,471 - $909,116	-8,279 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $170,410 - $207,324	1,729 Added 26.4%	8,279 $892,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $244,940 - $294,136	2,665 Added 68.6%	6,550 $717,000
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $335,042 - $372,649	3,885 New	3,885 $364,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcm Advisors, LLC with notifications on news.